Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients-Reference-Cited by-同舟云学术

Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients

Author:

Vincenti F.¹,Silva H. T.²,Busque S.³,O'Connell P. J.⁴,Russ G.⁵,Budde K.⁶,Yoshida A.⁷,Tortorici M. A.⁸,Lamba M.⁸,Lawendy N.⁸,Wang W.⁸,Chan G.⁸

Affiliation:

1. University of California; San Francisco CA

2. Hospital do Rim e Hipertensao; São Paulo Brazil

3. Stanford University; Stanford CA

4. Westmead Hospital; Westmead Australia

5. The Royal Adelaide Hospital; Adelaide Australia

6. Charité Universitätsmedizin Berlin; Berlin Germany

7. Henry Ford Hospital; Detroit MI

8. Pfizer Inc; Groton, CT Collegeville PA

Funder

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference23 articles.

5. Tofacitinib in combination with nonbiologic DMARDs in patients with active rheumatoid arthritis: A randomized trial;Kremer;Martin-Mola E,2013

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. JAK Inhibitors in Solid Organ Transplantation;The Journal of Clinical Pharmacology;2023-08-09